APROKAM 50 mg, powder for solution for injection 10 bottles
Active ingredients: Cefuroxime, Cefuroxime sodium
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injection10 bottlesintracamérulaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- APROKAM 50 mg, poudre pour solution injectable
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- intracamérulaire
- Presentation description
- 10 flacons en verre de 50 mg avec 10 aiguilles filtres de 5 microns stériles
- Marketing authorisation holder
- THEA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 5 Jul 2017
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60378168CIP75502851CIP133400955028512Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CÉFUROXIME SODIQUEpoudre | 52,6 mg · un flacon | SA |
| CÉFUROXIMEpoudre | 50 mg · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.